RecallDepth
Class II Ongoing

Duloxetine Delayed-Release Capsules, USP, 30 mg, 1,000 Capsules per bottle, Rx Only, Manufactured by: Towa Pharmaceutical Europe, S.L., Martorelles, (Barcelona), Spain. Manufactured for: Quallent Pharmaceuticals Health LLC, Grand Cayman, Cayman Islands. NDC: 82009-030-10

Company
Breckenridge Pharmaceutical, Inc.
Recall Initiated
August 8, 2025
Posted
September 17, 2025
Recall Number
D-0621-2025
Voluntary / Mandated
Voluntary: Firm initiated
Quantity
3,591 bottles
Firm Location
Berkeley Heights, NJ, United States

Reason for Recall

CGMP deviations: N-nitroso-duloxetine impurity above the proposed interim limit.

Distribution

AZ, IN, NJ

Lot / Code Info

Lot 240927C, Exp 04/30/2027

More recalls by Breckenridge Pharmaceutical, Inc.

View all recalls by this company →

Other recent Class II Drug recalls